Joel Savage en A trendy life, Communications and journalism, Healthcare Freelance Journalist, writer and author • A MIXTURE OF PERIODICALS 21/11/2016 · 2 min de lectura · +200

EBOLA COULD HAVE BEEN STOPPED BY THE END OF 2014

EBOLA COULD HAVE BEEN STOPPED BY THE END OF 2014


"Goodbye Ebola," they say but the disease is still a threat in West Africa


Teresa Romero tested positive and drew more than 375,000 signatures. At the same time in West Africa 10,000 infected poor people were dying and the West closed its borders. Nobody in the streets to protest 


By the middle of 2014, international health organizations and authorities knew they probably could stop Ebola by the end of the year, or even earlier, if they would properly peer various scientific studies, presented to them by Dr. David Fedson early August 2014, and by EBOLA ATTACK TEAM in Sierra Leone on 3 October 2014 about the promising effect of the oral medicines: Statin (Atorvastatin), Angiotensin Receptor Blocker (Irbesartan) and Selective Estrogen Receptor Modulator (Clomiphene). 

Unlike experimental Ebola treatments/vaccines, these drugs already had FDA & EMA approval since 30 years and are produced as inexpensive generics. The medicines are officially registered and for decades administered to millions of people around the world without serious side effects.

On 3 October 2014 the Ebola Attack Team members presented Dr. Fedson and colleagues’ thesis with Concordia medicines, studies and scientific reports to Professor Monty Jones who introduced it to the EOC (Emergency Operations Centre). 

The CDC USA, explicitly mentions on its website that “Clinical management of EVD should focus on supportive care of complications, such as septic shock” and that is precisely what EAT and its medical team proposed. Dr. Simona Zipursky, the W.H.O. representative in Sierra Leone and representatives of international health organizations, including CDC/USA, IMS, Red Cross and MSF aggressively turned against this promising protocol and started to indoctrinate the authorities and health care community to ignore and deny the proposed medication. 

Billions of Dollars were at stake and the Ebola Attack Team solution only cost a couple of millions from which they would not benefit. With petty cash the Ebola crisis could have been stopped before the end of 2014 but the global health organiza